Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nanorobotics logo — Leading developer of programmable, light-activated, nanorobo...

Nanorobotics

Leading developer of programmable, light-activated, nanorobots in medicine, targeting, destroying and curing cells

Founded 2019 Israel Israel 3 employees Biotechnology, Pharmaceutical

General Information

Company Name Nanorobotics
Founded Year 2019
Location Israel Israel
Employees 3
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Nanorobotics . To contact Nanorobotics , visit nanorobotics.tech.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Nanorobotics

Nanorobotics is a biotechnology and pharmaceutical startup based in Israel, founded in 2019. The company is gaining attention as a leading developer of programmable, light-activated nanorobots in medicine. With the slogan "Leading developer of programmable, light-activated, nanorobots in medicine, targeting, destroying and curing cells," Nanorobotics has developed proprietary technology using Molecular NanoMachines to promptly target and kill cancer cells. These tiny machines, measuring 1 nm in size, can mechanically kill cells by drilling and tunneling through the membrane until disrupting the nucleus. Nanorobotics is pioneering a new modality in oncology called Mechanotherapy. Recent animal studies have demonstrated a dramatic reduction in melanoma growth, particularly in cases highly resistant to immunotherapy. The company's Mechanotherapy treatment is notably decoupled from any cancer pathogenesis, mutational rate, or tumor microenvironment, highlighting its potential as a versatile and effective approach to cancer treatment. The development of programmable, light-activated nanorobots by Nanorobotics offers a revolutionary new area in nanomedicine, with significant potential for impacting the field of medicine. As of now, there is no information available on the last investment or the investors involved. Nanorobotics' approach to cancer treatment and technology presents a promising opportunity for investment in the biotechnology and pharmaceutical industries. Further monitoring and analysis of their progress in clinical trials and commercialization efforts are warranted for potential investors seeking opportunities in cutting-edge medical technologies.

Find out more at nanorobotics.tech.

Taxonomy: nanotechnology, nanomedicine, cancer treatment, oncology, nanorobotics, molecular nanomachines, mechanotherapy, programmable technology, light-activated, nanorobots, cancer research, cell targeting, animal studies, innovative medical technology

No funding data available for Nanorobotics yet.

Nanorobotics Alternatives & Competitors

Nanorobotics vs
Duo Oncology
Duo Oncology United States

Nanomedicines as the foundation of cancer medicine. Platform chemistry designed for patients.

Seed
4 employees
Biotechnology, Pharmaceutical
Nanorobotics vs
ARIZ Precision Medicine
ARIZ Precision Medicine United States

Targeting Cancer at the Root Cause

Seed
2 employees
Biotechnology, Health Care
Nanorobotics vs
MultiplexDX International
MultiplexDX International United States

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique...

Grant
37 employees
Biotechnology, Health Care

FAQ About Nanorobotics

Leading developer of programmable, light-activated, nanorobots in medicine, targeting, destroying and curing cells
Nanorobotics was founded in 2019.
Nanorobotics is headquartered in Israel.
Nanorobotics operates in Biotechnology and Pharmaceutical. Its work centres on nanotechnology, nanomedicine, cancer treatment and oncology.
Nanorobotics has approximately 3 employees.
Top alternatives and competitors to Nanorobotics include Duo Oncology, ARIZ Precision Medicine, MultiplexDX International, NanoCarrier Ltd., Novartis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanorobotics and Duo Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nanorobotics , https://bouncewatch.com/company/nanorobotics, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes